Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 1, 2004; 10(1): 136-142
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Figure 2 Changes in CD3+ cell percentages in perioperative period.
A: at randomization; B: before operation; C: on the 2nd postoperative day; and D: on the 10th postoperative day. The difference in CD3+ percentages between treatment and control groups at time points C and D was statistically significant, bP < 0.01. The difference in CD3+ percentages on the 10th postoperative day and the randomization day was statistically significant for both treatment and control groups, dP < 0.01.
- Citation: Lin CY, Bai DJ, Yuan HY, Wang K, Yang GL, Hu MB, Wu ZQ, Li Y. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial. World J Gastroenterol 2004; 10(1): 136-142
- URL: https://www.wjgnet.com/1007-9327/full/v10/i1/136.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i1.136